grant · US

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)

National Institutes of Health

AT A GLANCE

About this opportunity

National Institutes of Health lists this grant. The listed closing date is 15 Oct 2027. Check the official listing for details.

Who it’s for

Independent school districts; Public housing authorities/Indian housing authorities; State governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Private institutions of higher education; Native American tribal governments (Federally recognized); For profit organizations other than small businesses; Public and State controlled institutions of higher education; Native American tribal organizations (other than Federally recognized tribal governments); Small businesses; Special district governments; Others (see text field entitled "Additional Information on Eligibility" for clarification); City or township governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; County…

Explore related listings

General information only, not advice. Govlark lists public opportunities that look relevant to the description given; it does not assess eligibility and does not say you qualify. Always read the official listing and guidelines before applying.

Source: US Government work (public domain) · Source: Grants.gov · Report an error